Brief: Entera Bio Selected To Present At ASBMR 2021 Annual Meeting
01/09/2021 13:45
Sept 1 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO SELECTED FOR LATE BREAKING ORAL PRESENTATION OF
PHASE
2 6-MONTH OSTEOPOROSIS DATA AT ASBMR 2021 ANNUAL MEETING
Source text for Eikon: ID:nGNXcbbGZc
Further company coverage: 5DT.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement